O texto apresentado é obtido de forma automática, não levando em conta elementos gráficos e podendo conter erros. Se encontrar algum erro, por favor informe os serviços através da página de contactos.
Não foi possivel carregar a página pretendida. Reportar Erro

16 DE SETEMBRO DE 2016 23

General of the Council of Europe shall transmit certified copies to each member State of the Council of Europe,

to the non-member States which have participated in the elaboration of this Protocol, to any State invited to

accede to the Convention and to the European Community.

Appendix to the Additional Protocol on Biomedical Research

Information to be given to the ethics committee

Information on the following items shall be provided to the ethics committee, in so far as it is relevant for the

research project:

Description of the project

i the name of the principal researcher, qualifications and experience of researchers and, where

appropriate, the clinically responsible person, and funding arrangements;

ii the aim and justification for the research based on the latest state of scientific knowledge;

iii methods and procedures envisaged, including statistical and other analytical techniques;

iv a comprehensive summary of the research project in lay language;

v a statement of previous and concurrent submissions of the research project for assessment or approval

and the outcome of those submissions;

Participants, consent and information

vi justification for involving human beings in the research project;

vii the criteria for inclusion or exclusion of the categories of persons for participation in the research project

and how those persons are to be selected and recruited;

viii reasons for the use or the absence of control groups;

ix a description of the nature and degree of foreseeable risks that may be incurred through participating in

research;

x the nature, extent and duration of the interventions to be carried out on the research participants, and

details of any burden imposed by the research project;

xi arrangements to monitor, evaluate and react to contingencies that may have consequences for the

present or future health of research participants;

xii the timing and details of information for those persons who would participate in the research project and

the means proposed for provision of this information;

xiii documentation intended to be used to seek consent or, in the case of persons not able to consent,

authorisation for participation in the research project;

xiv arrangements to ensure respect for the private life of those persons who would participate in research

and ensure the confidentiality of personal data;

xv arrangements foreseen for information which may be generated and be relevant to the present or future

health of those persons who would participate in research and their family members;

Other information

xvi details of all payments and rewards to be made in the context of the research project;

xvii details of all circumstances that might lead to conflicts of interest that may affect the independent

judgement of the researchers;

xviii details of any foreseen potential further uses, including commercial uses, of the research results, data

or biological materials;

xix details of all other ethical issues, as perceived by the researcher;

xx details of any insurance or indemnity to cover damage arising in the context of the research project.

The ethics committee may request additional information necessary for evaluation of the research project.